Stocktoria
AVANOS MEDICAL, INC. AVNS
AVANOS MEDICAL, INC. (AVNS) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $701.2M at a -10.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.24 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.177 |
| Retained earnings / assets | -0.726 |
| EBIT / assets | -0.057 |
| Equity / liabilities | 2.634 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AVNS | AVANOS MEDICAL, INC. | 5/9 | 1.17 | — | +1.9% |
| CDRE | Cadre Holdings, Inc. | 6/9 | 3.7 | 27.2 | +7.5% |
| INGN | Inogen Inc | 4/9 | 2.26 | — | +3.9% |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | 4/9 | -2.1 | — | +27.1% |
| LAKE | LAKELAND INDUSTRIES INC | 2/9 | 4.56 | — | +15.2% |
| SMTI | Sanara MedTech Inc. | 4/9 | -1.26 | — | +19% |
| APT | ALPHA PRO TECH LTD | 4/9 | 12.4 | 16.1 | +2.3% |
About AVANOS MEDICAL, INC.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
FAQ
Is AVNS financially healthy?
AVANOS MEDICAL, INC.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does AVNS pay a dividend?
No, AVANOS MEDICAL, INC. does not currently pay a dividend.
How profitable is AVNS?
In FY2025, AVANOS MEDICAL, INC. had a net margin of -10.4% and a return on equity of -9.4%.
Is AVNS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on AVANOS MEDICAL, INC.: a Piotroski F-score of 5/9, an Altman Z″ in the grey zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.